Medical Research for Our Troops Act
Summary
HR3906 (Medical Research for Our Troops Act) would restore $1.181B in military medical research funding, but the bill has been stalled in the House Appropriations Committee since June 2025 with zero legislative movement. Real market data shows healthcare stocks declining 3-8% over 30 days due to broader sector headwinds, not this bill. No actionable trade signal exists.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR3906 is a stalled authorization bill with zero committee action since June 2025
- 2.The $1.181B funding restoration is not appropriated — it authorizes spending that requires separate appropriations bills
- 3.Healthcare stocks declining 3-8% over 30 days are driven by sector headwinds, not this dormant legislation
- 4.No actionable trade signal: the bill's passage probability is near zero in the current Congress
Market Implications
Zero market implications at current legislative stage. ($26.84), ($111.31), and ($316.60) are declining on unrelated healthcare sector pressure. Retail investors should ignore this bill as a trading catalyst. Any future movement would require the bill to advance out of committee and attract Republican support — track the House Appropriations Committee markup calendar, not stock prices.
Full Analysis
Rep. Carson (D-IN) introduced HR3906 on June 11, 2025, to restore $1.181B to the Defense Health Agency's research, development, test, and evaluation budget — specifically the Congressionally Directed Medical Research Programs (CDMRP). The bill targets a funding cut in the Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L. 119-4), reverting it to FY2024 levels. Since introduction, the bill has collected 48 cosponsors (all Democrats) and was referred to the House Committee on Appropriations — where it has remained for nearly 11 months without a hearing, markup, or vote.
The money trail is critical here: HR3906 is an authorization bill that would amend the existing appropriations act to restore spending levels. However, it does not directly appropriate new money — it authorizes the Secretary of Defense to obligate funds consistent with FY2024 levels. Actual disbursement requires the appropriations committee to include this language in a future spending bill. Given the bill's early-stage status and lack of committee action, there is effectively zero probability of near-term enactment.
Structural winners from this bill would be biopharma and medical device companies that participate in CDMRP's peer-reviewed grant programs — typically large pharma (, ), medical device manufacturers, and academic medical centers. However, no companies are named in the bill text, and CDMRP grants are competitive, not guaranteed. The defense healthcare sector (military treatment facilities, research labs) would be the direct beneficiary, but the stalled legislative path means ZERO current impact on revenue or earnings guidance.
Real market data confirms no bill-related impact: at $26.84 (-4.45% 30-day), at $111.31 (-7.47% 30-day), and at $316.60 (-3.65% 30-day) are all declining on broad healthcare sector weakness — likely tied to drug pricing policy uncertainty, patent cliff concerns, or macro rotation — not a stalled research funding bill no investor is watching.
Timeline: The bill requires (1) House Appropriations Committee markup and report, (2) House floor vote, (3) Senate companion bill and passage, (4) conference committee, and (5) presidential signature. Given zero actions in 11 months and a Democratic sponsor in a Republican-controlled House (119th Congress, Republican majority), the path to enactment is exceptionally narrow. No meaningful legislative catalysts expected before the 2028 elections.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Multiple independent sources confirm this signal’s market thesis
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
PANTEXAS DETERRENCE, LLC: $3.5B Department of Energy Contract
SPENCER CONSTRUCTION LLC: $1.1B Department of Homeland Security Contract
FISHER SAND & GRAVEL CO: $1.6B Department of Homeland Security Contract
FISHER SAND & GRAVEL CO: $2.6B Department of Homeland Security Contract
BARNARD SPENCER JOINT VENTURE: $634M Department of Homeland Security Contract
HII MISSION TECHNOLOGIES CORP: $579M General Services Administration Contract
VERTEX AEROSPACE LLC: $513M General Services Administration Contract
SPENCER CONSTRUCTION LLC: $512M Department of Homeland Security Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
National Security Presidential Memorandum/NSPM-11
This memorandum directs the national security enterprise (including the Department of War, intelligence agencies, and others) to accelerate the adoption, adaptation, and assurance of AI technologies for military and intelligence missions. It mandates updates to DOD Directive 3000.09 on autonomous weapons within 90 days, requires termination of contracts with companies that repeatedly violate policy (e.g., by enabling adversary control or embedding bias), and emphasizes supply chain resilience and multi-vendor sourcing to avoid single-vendor dependencies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Promoting Advanced Artificial Intelligence Innovation and Security
This executive order directs multiple federal agencies to prioritize cybersecurity hardening of national security, Department of War, and civilian government systems within 30 days. It establishes a classified benchmarking process for 'covered frontier models' and a voluntary framework for AI developers to provide early access to such models to the government for cybersecurity purposes. It also creates an AI cybersecurity clearinghouse, expands cybersecurity hiring pathways, and directs enforcement against AI-enabled computer crimes.